Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effects of CP-690,550 in subjects with psoriasis

Authors
Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2009
This article has no abstract
Epistemonikos ID: c2fc517dc581b2cf8cfcd50654631ee4aab72a50
First added on: Feb 28, 2025